Biosecurity

How can we prevent future pandemics and accelerate progress in the life sciences?

COVID-19 has revealed both strengths and weaknesses in our biosecurity response. On the one hand, the pandemic exposed how weak and ineffectual our public health systems are at controlling highly contagious airborne respiratory diseases. On the other hand, the urgency of the moment — combined with decades of previous investment — enabled us to deliver mRNA vaccines in less than nine months. The life sciences contain much more low-hanging fruit that is ripe to be picked — if only we can implement the right public policies.

Biosecurity
Latest Publication
Explaining Biden’s Pandemic Preparedness Budget: ASPR
Read the full report
May 19th 2022
Biosecurity
Weighing the Cost of the Pandemic
Knowing what we know now, how much damage did COVID-19 cause in the United States?
Read the full report
April 21st 2022
Biosecurity
Why BARDA Deserves More Funding
Read the full report
March 30th 2022
Biosecurity
Preventing Pandemics Requires Funding
Read the full report
March 14th 2022
Biosecurity
Comments on PREVENT Pandemics Discussion Draft
Read the full report
February 14th 2022
Biosecurity
Taking Emergency Use Authorization Seriously
Read the full report
January 27th 2022
Biosecurity
Creating Advance Market Commitments and Prizes for Pandemic Preparedness
Read the full report
January 19th 2022
Biosecurity
Curing Alzheimer’s by Investing in Aging Research
Read the full report
January 19th 2022